Claritev Corp CTEV
Business Services · IPO 2020 · data as of November 13, 2026
Claritev Corp (CTEV) is a consumer discretionary company listed in the US with a market value of about $458M. In the twelve months to September 30, 2026 it had revenue of $1.0B and net income of -$275M, a net margin of -27.1%.
Its overall Stock Analiz score is 0.8 out of 5 (weak). The strongest part is value (1/5); the weakest is financial health (0/5).
Key numbers: 5-year revenue growth of 1% a year, a 5-year average ROIC of -5%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 83% above the current price.
About Claritev
Claritev is listed in the US and classified in business services, IPO year 2020. Revenue went from $1.0B in 2018 to $965M in 2025, a decline of about 1.1% a year. It was profitable in 3 of the last 8 years in our data. Its share count rose by 3% over three years (dilution for shareholders).
Score: 0.8 / 5
Checks passed
- Price below intrinsic value (DCF, moderate assumptions)
- Profit margin improving
- ROE above 15%
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
Valuation
Growth and quality
Financials, last 8 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.0B | $965M | $931M | $962M | $1.1B | $1.1B | $938M | $983M | $1.0B |
| Net income | -$275M | -$284M | -$1.6B | -$92M | -$573M | $102M | -$521M | $10M | $36M |
| Free cash flow | -$28M | -$12M | -$11M | $63M | $283M | $320M | $307M | $218M | $229M |
| EPS (diluted) | $-16.42 | $-17.30 | $-101.92 | $-5.69 | $-36.00 | $6.40 | $-44.40 | $0.80 | $3.60 |
| Net margin | -27.1% | -29.4% | -176.8% | -9.5% | -53.1% | 9.1% | -55.5% | 1.0% | 3.5% |
| ROIC | — | 0.5% | -27.7% | 2.2% | -4.3% | 4.0% | -1.4% | 4.7% | 19.8% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 5 analysts is $48.60, 81% above the current price; targets range from $30.00 to $82.00; the consensus rating is “Buy”; expected EPS is $6.13 for the fiscal year ending December 31, 2026.
Frequently asked questions
Is Claritev stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 83% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Claritev pay a dividend?
Not currently.
Is Claritev a good stock to buy?
We do not give buy or sell advice. Claritev scores 0.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.